Cite
HARVARD Citation
Hata, S. et al. (2021). Degarelix as a neoadjuvant hormonal therapy for acute urinary tract toxicity associated with external beam radiotherapy for intermediate- and high-risk prostate cancer: a propensity score matched analysis. Japanese journal of clinical oncology. pp. 478-483. [Online].